General Information of the Compound
Compound ID
CP0014319
Compound Name
8-(3-methylsulfonylphenyl)-1-(oxan-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
    Show/Hide
Formula
C21H20N4O3S
Molecular Weight
408.483
Canonical SMILES
CS(=O)(=O)c1cccc(c1)-c1ccc2ncc3nnc(C4CCOCC4)n3c2c1
    Show/Hide
InChI
InChI=1S/C21H20N4O3S/c1-29(26,27)17-4-2-3-15(11-17)16-5-6-18-19(12-16)25-20(13-22-18)23-24-21(25)14-7-9-28-10-8-14/h2-6,11-14H,7-10H2,1H3
    Show/Hide
InChIKey
SISUIFVVYIBVIA-UHFFFAOYSA-N
Physicochemical Property
logP
3.242
Rotatable Bonds
3
Heavy Atom Count
29
Polar Areas
86.45
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4873491
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000154 HEK293-EBNA1-6E Homo sapiens (Human)  1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS